Welcome to our dedicated page for PAYCHEX SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Fidelity Brokerage Services LLC filed a Form 144 reporting a proposed sale of 459 shares of Common Stock of PAYX. The filing lists restricted stock vesting items of 07/15/2024 for 387 shares and 10/15/2024 for 72 shares.
PAYCHEX INC director Joseph M. Velli reported a routine options exercise. He exercised stock options covering 10,220 shares of common stock at an exercise price of $60.59 per share, described as options approaching their 10-year expiration date. Following the exercise, he directly holds 89,564 shares of PAYCHEX common stock.
He continues to hold multiple stock option awards on PAYCHEX common stock, with exercise prices ranging from $57.20 to $140.68 and expiration dates between 2027 and 2035. The filing shows an option exercise but no reported open-market sale of shares.
PAYCHEX INC major shareholder Thomas B. Golisano reported a bona fide gift of 109,300 shares of Paychex common stock on May 6, 2026. The shares were gifted to various non-profit organizations. Following the gift, he held 35,653,923 shares directly and 39,250 shares indirectly through the Cynthia A. Golisano Irrevocable Trust.
Paychex Rule 144 notice reports restricted/common shares sold by the B. Thomas Golisano Revocabl[e] Living Trust. The excerpt lists a sale of 109,300 shares dated 05/06/2026 and a sale of 163,930 shares dated 05/04/2026. The filing lists Merrill Lynch, Pierce, Fenner & Smith Incorporated as the broker and notes NASD in the securities line.
B. Thomas Golisano Revocable Living Trust reported a proposed sale of 163,930 shares of Common Stock of Paychex. The broker listed is Merrill Lynch, Pierce, Fenner & Smith Incorporated and the filing shows the date 05/04/2026.
PAYCHEX INC major shareholder Thomas B. Golisano reported a bona fide gift of 163,930 shares of common stock on May 4, 2026, described as a gift of shares to various non-profit organizations. The shares were valued at $93.21 each for reporting purposes.
After the gift, Golisano directly holds 35,763,223 shares of Paychex common stock and indirectly holds 39,250 shares through the Cynthia A. Golisano Irrevocable Trust U/A dated June 13, 2005. The filing shows a charitable transfer rather than an open-market sale or purchase.
Paychex Inc reporting person Vanguard Capital Management states it beneficially owns 24,271,194 shares of Common Stock, representing 6.77% of the class as of 03/31/2026. The filing attributes sole voting power for 3,305,924 shares and sole dispositive power for 24,271,194 shares. The report notes holdings include securities held by Vanguard funds and affiliated advisory units as described under SEC Release No. 34-39538.
Paychex Inc VP and Chief HR Officer Mason Argiropoulos reported a routine tax-withholding transaction related to equity compensation. On April 15, 2026, 79 shares of Paychex common stock were disposed of at $90.26 per share to satisfy tax withholding obligations from the vesting of restricted stock units. After this non‑market disposition, Argiropoulos directly holds 3,423 shares of common stock.
The filing also lists outstanding stock options over Paychex common stock, including options on 1,006 shares at an exercise price of $122.45 expiring on April 14, 2034, options on 11,909 shares at $121.63 expiring on July 14, 2034, and options on 11,075 shares at $140.68 expiring on July 14, 2035. The Employee Stock Purchase Plan balance is reported as 199.5 shares as of March 31, 2026.
PAYCHEX INC senior vice president Adam Brooks Ante reported a routine tax-related share disposition. On the lapse of restrictions on restricted stock and restricted stock units, 2,249 shares of common stock were withheld on April 1, 2026 at $90.91 per share to cover tax obligations, leaving him with 55,543 directly held shares.
He also continues to hold stock options covering 14,767 shares of common stock with an exercise price of $140.68 per share, expiring on July 14, 2035. The filing shows no open‑market purchases or sales, only tax withholding and existing option holdings.
PAYCHEX INC Chief Product Officer Ryan Norman Bergstrom reported a routine share withholding related to equity compensation. On the reported date, 1,374 shares of common stock were disposed of at $90.91 per share to satisfy tax withholding obligations from vesting restricted stock and restricted stock units. This was not an open-market trade but a mechanism to cover taxes.
After this tax withholding, Bergstrom directly holds 43,672 shares of PAYCHEX common stock. He also has outstanding stock options covering 14,767 underlying shares at a strike price of $140.68 per share, expiring in 2035, indicating a continuing long-term equity position.